Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Disrupting Ultrasound

This article was originally published in Start Up

Executive Summary

In ultrasound, small companies are few and far between; here, capital equipment companies rarely get venture backing, and the diversity of clinical segments that ultrasound serves requires sellers to have both large technical and marketing resources. But small companies like SonoSite, with new high-performing and lower-cost hand-held devices hope to disrupt the big-company, radiology-oriented status quo. The small companies are carving out some new non-radiology markets--guidance for catheter insertion, emergency medicine, Ob/Gyn and primary care--by positioning ultrasound as a new kind of triage tool.

You may also be interested in...



Resonant Medical

Resonant Medical has 510(k) approval for a multilevel platform for electronically collecting 3-D CT and ultrasound images from cancer patients in their planning and treatment stages.

Magnetic Moment

In terms of medical applications magnetic resonance imaging could serve, the modality is still underused, and that means a large, untapped growth opportunity for the entrenched large manufacturers that dominate the industry with an installed base of capital equipment. Small companies have a role to play as well, with adjunctive technologies that serve the large players, or in niches too small for the multi-billion dollar players to notice.

Magnetic Moment

In terms of medical applications magnetic resonance imaging could serve, the modality is still underused, and that means a large, untapped growth opportunity for the entrenched large manufacturers that dominate the industry with an installed base of capital equipment. Small companies have a role to play as well, with adjunctive technologies that serve the large players, or in niches too small for the multi-billion dollar players to notice.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel